Chill Brands Group PLC (CHBRF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Chill Brands Group PLC (CHBRF) with AI Score 38/100 (Weak). Chill Brands Group PLC focuses on the research, development, and sale of cannabidiol (CBD) consumer products and other lifestyle goods across the United States, the United Kingdom, and Europe. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Chill Brands Group PLC (CHBRF) Healthcare & Pipeline Overview
Chill Brands Group PLC is a UK-based company operating in the cannabidiol (CBD) consumer products market, offering tobacco alternatives and wellness products under the Chill.com and Zoetic brands, facing significant competition and financial challenges in the evolving regulatory landscape of the US, UK, and European markets.
Investment Thesis
Investing in Chill Brands Group PLC (CHBRF) presents significant risks due to its negative profitability, as evidenced by a -547.6% profit margin and a -48.1% gross margin. The company operates in a highly competitive and evolving regulatory environment within the CBD market. While the company has a presence in the US, UK, and Europe, its small market capitalization of $0.02 billion and negative P/E ratio of -1.35 indicate financial instability. Growth catalysts depend heavily on successful product launches and expansion into new markets, which are subject to regulatory approvals and market acceptance. The investment thesis hinges on the company's ability to achieve profitability and navigate the complex regulatory landscape, which is uncertain at this time.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.02 billion indicates a micro-cap company with high volatility potential.
- Negative profit margin of -547.6% reflects significant operational inefficiencies and challenges in achieving profitability.
- Gross margin of -48.1% suggests the company is selling products at a loss before considering operating expenses.
- The company operates in the rapidly evolving and highly competitive cannabidiol (CBD) market.
- Chill Brands Group PLC changed its name from Zoetic International PLC in August 2021, signaling a strategic shift in branding and market focus.
Competitors & Peers
Strengths
- Established brands (Chill.com and Zoetic).
- Presence in multiple geographic markets (US, UK, Europe).
- Diverse product portfolio of CBD-infused products.
Weaknesses
- Negative profit margin and gross margin.
- Small market capitalization.
- Limited financial resources.
Catalysts
- Upcoming: Potential regulatory changes in the US, UK, and Europe regarding CBD products could create new market opportunities or pose additional challenges.
- Ongoing: Expansion of the company's product portfolio with new CBD-infused products targeting specific health and wellness needs.
- Ongoing: Strategic partnerships with established retailers and distributors to expand market reach.
- Ongoing: Increased consumer awareness of the potential health benefits of CBD products.
- Ongoing: Development of a strong online presence and e-commerce platform to drive direct-to-consumer sales.
Risks
- Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.
- Ongoing: Intense competition in the CBD market from established players and new entrants.
- Potential: Fluctuations in consumer demand for CBD products.
- Potential: Negative publicity or adverse health effects associated with CBD products.
- Ongoing: Limited financial resources and negative profitability.
Growth Opportunities
- Expansion into new geographic markets represents a significant growth opportunity for Chill Brands. The company currently operates in the US, UK, and Europe, but further expansion into other regions with favorable regulatory environments could drive revenue growth. Successfully entering new markets requires significant investment in marketing, distribution, and regulatory compliance, but the potential rewards could be substantial. The global cannabis market is projected to reach $47 billion by 2027, presenting a large addressable market for Chill Brands.
- Development of new CBD-infused products targeting specific health and wellness needs could drive revenue growth and increase market share. Chill Brands currently offers a range of products, including tobacco alternatives, tinctures, and topical creams, but expanding its product portfolio to address specific conditions such as anxiety, sleep disorders, and pain management could attract new customers and increase customer loyalty. This requires investment in research and development, as well as clinical trials to validate the efficacy of new products. The market for CBD-infused health and wellness products is growing rapidly, driven by increasing consumer awareness of potential health benefits.
- Strategic partnerships with established retailers and distributors could significantly expand Chill Brands' market reach and increase brand awareness. Collaborating with major retailers in the US, UK, and Europe could provide access to a large customer base and enhance brand visibility. This requires negotiating favorable terms and ensuring consistent product quality and supply. The retail landscape is evolving rapidly, with increasing demand for CBD products in mainstream retail channels.
- Focus on building a strong online presence and e-commerce platform could drive direct-to-consumer sales and increase brand loyalty. Investing in search engine optimization (SEO), social media marketing, and targeted advertising could attract new customers and increase online sales. This requires building a user-friendly website, offering competitive pricing, and providing excellent customer service. The e-commerce channel is growing rapidly, driven by increasing consumer preference for online shopping.
- Lobbying and advocacy efforts to influence regulatory policies and promote favorable legislation could create a more supportive environment for the CBD industry and benefit Chill Brands. Engaging with policymakers and industry associations to advocate for clear and consistent regulations could reduce uncertainty and create a more level playing field for all companies. This requires investing in government relations and building strong relationships with key stakeholders. The regulatory landscape for CBD is constantly evolving, and proactive engagement with policymakers is essential for long-term success.
Opportunities
- Expansion into new geographic markets.
- Development of new CBD-infused products.
- Strategic partnerships with established retailers.
Threats
- Evolving regulatory landscape for CBD products.
- Intense competition in the CBD market.
- Fluctuations in consumer demand for CBD products.
Competitive Advantages
- Brand recognition through the Chill.com and Zoetic brands.
- Proprietary formulations and manufacturing processes for CBD products.
- Established distribution network in the US, UK, and Europe.
About CHBRF
Chill Brands Group PLC, formerly known as Zoetic International PLC, was founded in 2014 and rebranded in August 2021 to reflect its strategic focus on the 'Chill' brand. Headquartered in London, the company operates in the cannabidiol (CBD) consumer products and lifestyle goods sector, with a presence in the United States, the United Kingdom, and Europe. Chill Brands develops, produces, and sells a variety of CBD-infused products, including tobacco alternative products such as smokes and chew pouches, catering to consumers seeking alternatives to traditional tobacco products. The company also offers oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products, targeting the broader wellness market. These products are marketed under the Chill.com and Zoetic brands, with the Chill.com brand representing the company's primary focus. Despite its presence in multiple geographic markets, Chill Brands faces challenges related to regulatory uncertainties and intense competition within the rapidly evolving CBD industry. The company's ability to navigate these challenges and establish a sustainable market position will be critical to its long-term success.
What They Do
- Researches and develops cannabidiol (CBD) consumer products.
- Produces a range of CBD-infused products, including tobacco alternatives.
- Sells CBD products in the United States, the United Kingdom, and Europe.
- Offers tobacco alternative products like smokes and chew pouches.
- Provides oral tinctures and soft-gel capsules.
- Manufactures massage oils and topical cosmetic products.
- Markets its products under the Chill.com and Zoetic brands.
Business Model
- Develops and manufactures CBD-infused consumer products.
- Sells products through online channels and retail partnerships.
- Generates revenue from the sale of CBD products in the US, UK, and Europe.
Industry Context
Chill Brands Group PLC operates within the rapidly expanding yet highly fragmented cannabidiol (CBD) market. This market is characterized by evolving regulations, intense competition, and fluctuating consumer demand. The global CBD market is projected to reach billions of dollars in the coming years, driven by increasing consumer awareness of potential health benefits and the legalization of cannabis in various jurisdictions. However, regulatory uncertainties and varying standards across different countries pose significant challenges for companies like Chill Brands. Competitors such as ATHJF (Australis Capital Inc.), BFFTF (BevCanna Enterprises Inc.), EMMLF (Emerald Health Therapeutics Inc.), GENH (General Hemp Corp), and GRAMF (The Gram Co Inc.) are vying for market share, intensifying the competitive landscape.
Key Customers
- Consumers seeking alternatives to traditional tobacco products.
- Individuals interested in CBD-infused wellness products.
- Customers in the United States, the United Kingdom, and Europe.
Financials
Chart & Info
Chill Brands Group PLC (CHBRF) stock price: Price data unavailable
Latest News
No recent news available for CHBRF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHBRF.
Price Targets
Wall Street price target analysis for CHBRF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CHBRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Graham John William Duncan
CEO
Graham John William Duncan serves as the CEO of Chill Brands Group PLC, leading a team of 7 employees. His background includes experience in managing and developing consumer product companies, with a focus on strategic growth and market expansion. He has been instrumental in guiding the company through its rebranding and strategic shift towards the 'Chill' brand. His expertise lies in navigating the complex regulatory landscape of the CBD industry and building partnerships to drive revenue growth.
Track Record: Under Graham Duncan's leadership, Chill Brands Group PLC has focused on expanding its product portfolio and market presence in the US, UK, and Europe. Key milestones include the rebranding from Zoetic International PLC to Chill Brands Group PLC and the launch of new CBD-infused products. However, the company continues to face challenges related to profitability and market competition.
CHBRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Chill Brands Group PLC may not meet the minimum financial or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity, lack of transparency, and higher risk of fraud or manipulation. This tier is generally reserved for companies with distressed financials, shell corporations, or those that choose not to comply with higher reporting standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price volatility and manipulation.
- Higher risk of fraud or misrepresentation.
- Limited financial disclosure and transparency.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Company has a registered business address in London.
- Company has a functional website and online presence.
- Company has a CEO and management team.
- Company has been in operation since 2014.
- Company has a product portfolio of CBD-infused products.
Chill Brands Group PLC Stock: Key Questions Answered
What does Chill Brands Group PLC do?
Chill Brands Group PLC operates in the cannabidiol (CBD) consumer products market, focusing on the research, development, production, and sale of CBD-infused goods. The company offers a range of products, including tobacco alternatives like smokes and chew pouches, as well as oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products. These products are marketed under the Chill.com and Zoetic brands and are sold in the United States, the United Kingdom, and Europe. The company aims to capitalize on the growing demand for CBD products by offering a diverse portfolio of wellness-focused items.
What do analysts say about CHBRF stock?
As of 2026-03-16, there is no readily available analyst consensus on CHBRF stock due to its OTC listing and small market capitalization. Key valuation metrics such as the negative P/E ratio of -1.35 and negative profit margin of -547.6% suggest financial challenges. Growth considerations depend on the company's ability to navigate the evolving regulatory landscape, expand its product portfolio, and achieve profitability. Investors should conduct thorough due diligence and consider the risks associated with investing in OTC-listed stocks.
What are the main risks for CHBRF?
Chill Brands Group PLC faces several key risks, including the evolving regulatory landscape for CBD products in the US, UK, and Europe, which could impact its ability to market and sell its products. Intense competition in the CBD market from established players and new entrants poses a threat to its market share. Fluctuations in consumer demand for CBD products and potential negative publicity or adverse health effects associated with CBD could also negatively impact the company's performance. Additionally, the company's limited financial resources and negative profitability present significant challenges to its long-term sustainability.
What are the key factors to evaluate for CHBRF?
Chill Brands Group PLC (CHBRF) currently holds an AI score of 38/100, indicating low score. Key strength: Established brands (Chill.com and Zoetic).. Primary risk to monitor: Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.. This is not financial advice.
How frequently does CHBRF data refresh on this page?
CHBRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CHBRF's recent stock price performance?
Recent price movement in Chill Brands Group PLC (CHBRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands (Chill.com and Zoetic).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CHBRF overvalued or undervalued right now?
Determining whether Chill Brands Group PLC (CHBRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CHBRF?
Before investing in Chill Brands Group PLC (CHBRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC market stocks have higher risk than exchange listed stocks.
- Financial data is limited.